Axsome Therapeutics, Inc.
AXSMBiotechnology
$144.43+0.68%As of Oct 30vs prior close
- Market cap
- $7.6B
- P/E (TTM)
- –
- From 52W high
- −43.40%
- EPS (LTM)
- -$3.74
- Revenue (LTM)
- $776.6M
- Net margin
- -24.68%
- Dividend yield
- 0.00%
Nomior Score
59
Ascendant MoverSpeculativeTop 29% of the scored universe
Growth73
Quality40
Value57
Momentum71
Resilience39
Growth
+133.68%revenue a year over 3 fiscal years
YE22 $50MLTM $776.6M
Connections
Revenue to profitQ2 YE26
The operating loss was 23% of revenue, narrower by 2 pts on a year.
Who owns it
1fund, 2 tracked portfolios